NCT06703099

Brief Summary

The goal of this interventional clinical trial is to learn if the supplementation of magnesium can affect body composition in physically active individuals between the ages of 18 and 30. The main question\[s\] it aims to answer \[is/are\]: How does magnesium supplementation affect body composition in physically active individuals? Participants will take a magnesium capsule once daily for 8 weeks, log their food intake into MyFitnessPal 3 days weekly for the 8 weeks, keep their physical activity consistent to their current regimen, and have 1 baseline appointment with 2 follow ups evenly dispersed (mid-point and post-intervention).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 25, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2025

Completed
Last Updated

June 6, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

November 10, 2024

Last Update Submit

June 5, 2025

Conditions

Keywords

body compositionmagnesiumlean body massInBodyActivePilot study

Outcome Measures

Primary Outcomes (4)

  • Body Composition - BMI

    Using the InBody 270, height and weight will be combined to report BMI (kg/m2)

    8 weeks

  • Body Composition - Weight

    Using the InBody 270, weight will be reported in pounds (lb)

    8 weeks

  • Body Composition - LBM

    Using the InBody 270, lean body mass (LBM) will be reported in pounds (lb)

    8 weeks

  • Body Composition - BFM

    Using the InBody 270, body fat mass (BFM) will be reported in pounds (lb)

    8 weeks

Secondary Outcomes (1)

  • Dietary Intake

    8 weeks

Study Arms (1)

Magnesium Supplementation

EXPERIMENTAL

Life Extension® Extend Release Magnesium 250 mg/day of oral magnesium in capsule form to be taken once a day at breakfast/morning.

Dietary Supplement: Magnesium Supplementation

Interventions

Magnesium SupplementationDIETARY_SUPPLEMENT

Life Extension® Extend Release Magnesium 250 mg/day of oral magnesium in capsule form to be taken once a day at breakfast/morning over 8 weeks.

Magnesium Supplementation

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • classified as a physically active individual for at least 1 year defined as being any individual that regularly engages in the minimum physical activity requirements as put forth by the American College of Sports Medicine.
  • have a BMI of 19-30 kg/m2

You may not qualify if:

  • smokers
  • have been diagnosed with any metabolic/chronic disease
  • are taking medications that can interfere with body composition
  • are unwilling to follow study guidelines
  • have a current physical condition that may be exacerbated by physical activity as determined by their general practitioner
  • are pregnant or intend to become pregnant within 3 months
  • have taken Mg supplements within the last 6 months
  • are using steroids or any anabolic agents
  • have pacemakers, implants, or any non-removable metal surgical implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nova Southeastern University HPD Annex Building

Davie, Florida, 33328, United States

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Madison M Doten, BS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2024

First Posted

November 25, 2024

Study Start

September 25, 2024

Primary Completion

March 20, 2025

Study Completion

April 27, 2025

Last Updated

June 6, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Statistical analysis of data will be shared, however individual documentation for participants will be kept on file and destroyed after 36 months as per IRB protocol. These documents will not be available to other researchers.

Locations